Arc Bio Communications Limited
Registered name: ARC BIO COMMUNICATIONS LIMITED
Part of Iqvia Holdings Inc. groupArc Bio Communications Limited made £1.8m profit in the year to 31 Dec 2025 (revenue not disclosed).
Arc Bio Communications Limited reported £1.8m profit in the year to 31 Dec 2025, down 24% on the year before; its revenue was not disclosed. It had 13 employees. The company is classified under “media representation services” and is based in Reading; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Reading, South East
- Age
- 10 yrs · since 2016
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|
| Disclosure | Profit only | Profit only |
| Profit & loss | ||
| Revenue (turnover) | — | — |
| Profit after tax | £2.4m | £1.8m |
| Profit (best available) | £2.4m | £1.8m |
| Employees (average) | 39 | 13 |
| Ratios | ||
| Profit margin | — | — |
| Profit per employee | £60.4k | £138k |
| Growth (year on year) | ||
| Profit growth | — | ▼24% |
| Headcount growth | — | ▼66.7% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £1.6m | £3.5m |
| Net assets | £3.3m | £5.1m |
| Fixed assets | £16.7k | — |
| Current assets | £5m | £7.7m |
| Debtors | £1.7m | £1.8m |
| Deferred income | £853k | £418k |
| Source | FullAccounts · bulk data Sep 2026 | FullAccounts · bulk data Sep 2026 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- £138k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲55%
- Now £5.1m
- Cash at bank
- ▲121%
- Now £3.5m
- Headcount
- ▼67%
- Now 13
- Deferred income
- ▼51%
- Now £418k
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Iqvia Holdings Inc. (registered outside the UK register)ultimate parent75–100%
- Iqvia RDS UK Holdings Ltd.75–100%
- Iqvia RDS Holdings75–100%
- Iqvia Ltd.75–100%
- Arc Bio Communications Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (28)
- Interface Clinical Services LtdRev. £26.3m · Profit £5.9m
- Oxford Conversis LimitedRev. £7.7m · Profit −£90.5k
- Pharmareview LimitedRev. £6m · Profit £47.8m
- Epg Communication Holdings LimitedRev. £2.5m · Profit −£4.3m
- Apira LimitedFigures not disclosed
- Clintec International Ltd.Figures not disclosed
- Cro Solutions LimitedRev. — · Profit £1.1m
- Drugdev LimitedFigures not disclosed
- Gce Clin Solutions LimitedFigures not disclosed
- Healthcare Business Information LimitedFigures not disclosed
- Ims (UK) Pension Plan Trustee Company LimitedFigures not disclosed
- Iqvia Biotech Ltd.Figures not disclosed
- Iqvia Investment Holdings LimitedFigures not disclosed
- Iqvia Solutions Finance UK V Ltd.Figures not disclosed
- Iqvia Solutions UK LimitedFigures not disclosed
- Iqvia Technology Services Ltd.Figures not disclosed
- LH Perspectives LimitedFigures not disclosed
- Linguamatics LimitedFigures not disclosed
- Linguamatics Solutions LimitedFigures not disclosed
- Medicines Evaluation Unit LimitedRev. — · Profit £2.4m
- Optimum Contact LimitedFigures not disclosed
- Pharmadeals LimitedFigures not disclosed
- Pharmaspectra Group LtdRev. — · Profit £1.6m
- Pharmaspectra Topco LtdLiquidationFigures not disclosed
- PHR Topco LimitedLiquidationRev. — · Profit −£1.8m
- Prioritis LimitedFigures not disclosed
- Q Squared Solutions Holdings LimitedFigures not disclosed
- QH Research LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Teads LimitedLondon · Media representation services
- Revenue
- £56.2m
- Profit
- £6.6m
- Staff
- 122
- Real Chemistry UK LtdLondon · Media representation services
- Revenue
- £50.7m
- Profit
- £2.7m
- Staff
- 291
- Brand Fuel LimitedLondon · Media representation services
- Revenue
- £49.4m
- Profit
- £1.4m
- Staff
- 75
- Sleek Events Ltd.Wimbledon · Media representation services
- Revenue
- £34.6m
- Profit
- £1.3m
- Staff
- 46
- The Media People LimitedLondon · Media representation services
- Revenue
- £37m
- Profit
- £797k
- Staff
- 78
- Zeal Creative LimitedBury · Media representation services
- Revenue
- £17.6m
- Profit
- £769k
- Staff
- 106
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £1.8m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.